These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14683515)

  • 1. Vitamin D analogs as modulators of vitamin D receptor action.
    Peleg S; Posner GH
    Curr Top Med Chem; 2003; 3(14):1555-72. PubMed ID: 14683515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Structural refinement of seco-steroidal skeleton and the biological activity through nuclear receptors].
    Kittaka A
    Yakugaku Zasshi; 2008 Sep; 128(9):1235-50. PubMed ID: 18758137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of stereochemistry on the actions of vitamin D.
    Chiellini G; DeLuca HF
    Curr Top Med Chem; 2011; 11(7):840-59. PubMed ID: 21291397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings.
    Verstuyf A; Verlinden L; Van Baelen H; Sabbe K; D'Hallewyn C; De Clercq P; Vandewalle M; Bouillon R
    J Bone Miner Res; 1998 Apr; 13(4):549-58. PubMed ID: 9556055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent progress of study on vitamin D analogs].
    Kittaka A; Saito N; Takano M
    Clin Calcium; 2006 Jul; 16(7):1154-65. PubMed ID: 16816476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
    Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
    Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D analogs as anti-carcinogenic agents.
    Agoston ES; Hatcher MA; Kensler TW; Posner GH
    Anticancer Agents Med Chem; 2006 Jan; 6(1):53-71. PubMed ID: 16475927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells.
    Nakagawa K; Kurobe M; Ozono K; Konno K; Fujishima T; Takayama H; Okano T
    Biochem Pharmacol; 2000 Mar; 59(6):691-702. PubMed ID: 10677586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 25-hydroxyl group orientation on biological activity and binding to the 1alpha,25-dihydroxy vitamin D3 receptor.
    Collins ED; Bishop JE; Bula CM; Acevedo A; Okamura WH; Norman AW
    J Steroid Biochem Mol Biol; 2005 Mar; 94(4):279-88. PubMed ID: 15857747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
    Shimizu M; Miyamoto Y; Takaku H; Matsuo M; Nakabayashi M; Masuno H; Udagawa N; DeLuca HF; Ikura T; Ito N
    Bioorg Med Chem; 2008 Jul; 16(14):6949-64. PubMed ID: 18539034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncalcemic actions of vitamin D receptor ligands.
    Nagpal S; Na S; Rathnachalam R
    Endocr Rev; 2005 Aug; 26(5):662-87. PubMed ID: 15798098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological studies of the A-ring-modified 1,25-dihydroxyvitamin D3 analogs.
    Takayama H; Kittaka A; Fujishima T; Suhara Y
    Recent Results Cancer Res; 2003; 164():289-317. PubMed ID: 12899530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D receptor agonists: opportunities and challenges in drug discovery.
    Takahashi T; Morikawa K
    Curr Top Med Chem; 2006; 6(12):1303-16. PubMed ID: 16848744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural development of p-carborane-based potent non-secosteroidal vitamin D analogs.
    Fujii S; Sekine R; Kano A; Masuno H; Songkram C; Kawachi E; Hirano T; Tanatani A; Kagechika H
    Bioorg Med Chem; 2014 Nov; 22(21):5891-901. PubMed ID: 25284253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular tools for study of genomic and rapid signal transduction responses initiated by 1 alpha,25(OH)(2)-vitamin D(3).
    Norman AW; Bishop JE; Bula CM; Olivera CJ; Mizwicki MT; Zanello LP; Ishida H; Okamura WH
    Steroids; 2002 May; 67(6):457-66. PubMed ID: 11960621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Studies of Vitamin D Nuclear Receptor Ligand-Binding Properties.
    Belorusova AY; Rochel N
    Vitam Horm; 2016; 100():83-116. PubMed ID: 26827949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of vitamin D receptor action.
    Issa LL; Leong GM; Eisman JA
    Inflamm Res; 1998 Dec; 47(12):451-75. PubMed ID: 9892040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of the selective activity of vitamin D analogues.
    Carlberg C
    J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of triple bond and adamantane ring on the vitamin D side chain produced partial agonists for vitamin D receptor.
    Kudo T; Ishizawa M; Maekawa K; Nakabayashi M; Watarai Y; Uchida H; Tokiwa H; Ikura T; Ito N; Makishima M; Yamada S
    J Med Chem; 2014 May; 57(10):4073-87. PubMed ID: 24773565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.